SCHEMBL16623788

SCHEMBL16623788

c1cc2ccc3c4c5c(ccc6cccc(c(c1)c24)c65)N1c2ccc4cccc5c6cccc7ccc(c(c2c45)c76)C31

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HPGD P15428 4/20 0.48
HSD17B10 Q99714 4/20 0.48
CYP1A2 P05177 3/20 0.48
THRB P10828 1/20 0.48
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
TSHR P16473 3/20 0.36
CYP3A4 P08684 2/20 0.36
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623775 0.79 ALDH1A1 (0.40) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16623776 0.75 ALDH1A1 (0.38) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL30236746 0.72 ALDH1A1 (0.88) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL606940 0.70 ALDH1A1 (0.82) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL29370709 0.70 ALDH1A1 (0.82) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL29375094 0.70 ALDH1A1 (0.82) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16623771 0.69 GPR3 (0.41) ALDH1A1CYP1A2CYP3A4KDM4EKMT2A
Benzo[E]Pyrene SCHEMBL24020 0.67 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10CYP1A2THRB
Benzo[E]Pyrene SCHEMBL4983272 0.67 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10CYP1A2THRB
Benzo[E]Pyrene SCHEMBL29357057 0.67 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047913-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE JNC CORPORATION (JP) 2018-02-15 US disclosed
US-9741950-B2 Polycyclic aromatic compound KYOTO UNIVERSITY (JP) 2017-08-22 US disclosed
US-20160049600-A1 POLYCYCLIC AROMATIC COMPOUND SK MATERIALS JNC CO., LTD. (KR) 2016-02-18 US disclosed
US-9166176-B2 Polycyclic aromatic compound KYOTO UNIVERSITY (JP) 2015-10-20 US disclosed
US-20150097162-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE JNC CORPORATION (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047913-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE L1CAM, VDAC1, VDAC2 ALDH1A1 2463/4885HPGD 3876/4885HSD17B10 4406/4885
US-20160049600-A1 POLYCYCLIC AROMATIC COMPOUND BICRA, PAH, SMARCC2 ALDH1A1 1610/4885HPGD 3954/4885HSD17B10 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.